These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 36298824)

  • 21. Novel coronavirus disease 2019 (COVID-19) and neurodegenerative disorders.
    Singh AK; Bhushan B; Maurya A; Mishra G; Singh SK; Awasthi R
    Dermatol Ther; 2020 Jul; 33(4):e13591. PubMed ID: 32412679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune profiling of SARS-CoV-2 epitopes in asymptomatic and symptomatic pediatric and adult patients.
    Tornesello AL; Botti C; Micillo A; Labonia F; Arpino S; Isgrò MA; Meola S; Russo L; Cavalcanti E; Sale S; Nicastro C; Atripaldi L; Starita N; Cerasuolo A; Reimer U; Holenya P; Buonaguro L; Buonaguro FM; Tornesello ML
    J Transl Med; 2023 Feb; 21(1):123. PubMed ID: 36788606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms.
    Troyer EA; Kohn JN; Hong S
    Brain Behav Immun; 2020 Jul; 87():34-39. PubMed ID: 32298803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropsychiatric Symptoms of COVID-19 Explained by SARS-CoV-2 Proteins' Mimicry of Human Protein Interactions.
    Yapici-Eser H; Koroglu YE; Oztop-Cakmak O; Keskin O; Gursoy A; Gursoy-Ozdemir Y
    Front Hum Neurosci; 2021; 15():656313. PubMed ID: 33833673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioinformatics and system biology approaches to identify pathophysiological impact of COVID-19 to the progression and severity of neurological diseases.
    Rahman MH; Rana HK; Peng S; Kibria MG; Islam MZ; Mahmud SMH; Moni MA
    Comput Biol Med; 2021 Nov; 138():104859. PubMed ID: 34601390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequence similarity between SARS-CoV-2 nucleocapsid and multiple sclerosis-associated proteins provides insight into viral neuropathogenesis following infection.
    Lake CM; Breen JJ
    Sci Rep; 2023 Jan; 13(1):389. PubMed ID: 36617594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1.
    Pagano S; Yerly S; Meyer B; Juillard C; Suh N; Le Terrier C; Daguer JP; Farrera-Soler L; Barluenga S; Piumatti G; Hartley O; Lemaitre B; Eberhardt CS; Siegrist CA; Eckerle I; Stringhini S; Guessous I; Kaiser L; Pugin J; Winssinger N; Vuilleumier N
    Eur J Clin Invest; 2021 Nov; 51(11):e13661. PubMed ID: 34324704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up.
    Kanberg N; Simrén J; Edén A; Andersson LM; Nilsson S; Ashton NJ; Sundvall PD; Nellgård B; Blennow K; Zetterberg H; Gisslén M
    EBioMedicine; 2021 Aug; 70():103512. PubMed ID: 34333238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2.
    Chen HZ; Tang LL; Yu XL; Zhou J; Chang YF; Wu X
    Infect Dis Poverty; 2020 Jul; 9(1):88. PubMed ID: 32741372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
    Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
    J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19 and neurological disorders: are neurodegenerative or neuroimmunological diseases more vulnerable?
    Ferini-Strambi L; Salsone M
    J Neurol; 2021 Feb; 268(2):409-419. PubMed ID: 32696341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammation at the crossroads of COVID-19, cognitive deficits and depression.
    Lyra E Silva NM; Barros-Aragão FGQ; De Felice FG; Ferreira ST
    Neuropharmacology; 2022 May; 209():109023. PubMed ID: 35257690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlates with Vaccine Protective Capacity and COVID-19 Disease Symptoms Identified by Serum Proteomics in Vaccinated Individuals.
    Villar M; Urra JM; Artigas-Jerónimo S; Mazuecos L; Contreras M; Vaz-Rodrigues R; Rodríguez-Del-Río FJ; Gortázar C; de la Fuente J
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRESSP: a comprehensive pipeline for prediction of immunopathogenic SARS-CoV-2 epitopes using structural properties of proteins.
    An H; Eun M; Yi J; Park J
    Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35226074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19 and Neurodegenerative Diseases: Prion-Like Spread and Long-Term Consequences.
    Baazaoui N; Iqbal K
    J Alzheimers Dis; 2022; 88(2):399-416. PubMed ID: 35599487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of COVID-19 on diagnostic biomarkers in neuropsychiatric and neuroimmunological diseases: a review.
    Dadkhah M; Talei S; Doostkamel D; Molaei S; Rezaei N
    Rev Neurosci; 2022 Jan; 33(1):79-92. PubMed ID: 34087964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review.
    Sriwastava S; Tandon M; Kataria S; Daimee M; Sultan S
    J Neurol; 2021 Aug; 268(8):2690-2696. PubMed ID: 33047223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung disease network reveals impact of comorbidity on SARS-CoV-2 infection and opportunities of drug repurposing.
    Das AB
    BMC Med Genomics; 2021 Sep; 14(1):226. PubMed ID: 34535131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted.
    Borah P; Deb PK; Chandrasekaran B; Goyal M; Bansal M; Hussain S; Shinu P; Venugopala KN; Al-Shar'i NA; Deka S; Singh V
    Front Mol Biosci; 2021; 8():627723. PubMed ID: 33681293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokine storm and neuropathological alterations in patients with neurological manifestations of COVID-19.
    Tsagkaris C; Bilal M; Aktar I; Aboufandi Y; Tas A; Aborode AT; Suvvari TK; Ahmad S; Shkodina A; Phadke R; Emhamed MS; Baig AA; Alexiou A; Ashraf GM; Kamal MA
    Curr Alzheimer Res; 2022 Sep; ():. PubMed ID: 36089786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.